Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1998
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011204A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998WO1998011202A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998WO1998011140A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998WO1998011139A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
03/19/1998WO1998011138A1 Chemokine alpha-4
03/19/1998WO1998011137A1 Use of proteins as anti-retroviral agents
03/19/1998WO1998011136A1 A cDNA AND PEPTIDE WITH RELATION TO CANCER AND WEIGHT LOSS
03/19/1998WO1998011135A1 A taxol-like protein (talp) and process for preparing the same
03/19/1998WO1998011133A1 New picornaviruses, vaccines and diagnostic kits
03/19/1998WO1998011132A1 An immunogenic determinant for use in the diagnosis of kaposi's sarcoma
03/19/1998WO1998011130A2 Mammalian ependymin-like proteins
03/19/1998WO1998011129A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
03/19/1998WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
03/19/1998WO1998011127A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998WO1998011126A1 Peptide prodrugs containing an alpha-hydroxyacid linker
03/19/1998WO1998011117A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998WO1998011116A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010794A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010791A1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
03/19/1998WO1998010789A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010786A2 Pharmaceutical composition for the treatment of syndrome x of reaven
03/19/1998WO1998010785A1 Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders
03/19/1998WO1998010784A1 Method of preventing tissue injury
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010782A1 Antifungal combination therapy
03/19/1998WO1998010781A1 Means for treating prostate hypertrophy and prostate cancer
03/19/1998WO1998010780A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
03/19/1998WO1998010779A1 Method for treating parasitic diseases with proteasome inhibitors
03/19/1998WO1998010778A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
03/19/1998WO1998010777A1 Nucleosome-based anti-tumor compositions
03/19/1998WO1998010776A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
03/19/1998WO1998010775A1 Composition and method for repairing neurological tissue
03/19/1998WO1998010749A1 Protein-lipid vesicles and autogenous vaccine comprising the same
03/19/1998WO1998010747A1 Immunomodulatory formulation
03/19/1998WO1998010743A1 Composition for treating acne
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998WO1998010651A1 Conjugates useful in the treatment of prostate cancer
03/19/1998WO1998010650A1 Method of treating endothelial injury
03/19/1998WO1998010649A1 Biocompatible cationic detergents and uses therefor
03/19/1998WO1998010638A1 Therapeutic molecules
03/19/1998WO1998005777A3 BCL-xη, A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO
03/19/1998WO1998002554A3 Cytochrome P450 expression in enterobacteria
03/19/1998WO1998001158A3 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers
03/19/1998WO1998000541A3 Methods for administration of recombinant gene delivery vehicles for treatment of human disease
03/19/1998WO1997038110A3 Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases
03/19/1998DE19637947A1 Nukleinsäure-Konstrukt kodierend für einen Proteinkomplex aus Stat-Protein und nukleären Rezeptor und seine Verwendung Nucleic acid construct encoding a protein complex from Stat-protein and nuclear receptor and its use
03/19/1998DE19637230A1 Truncated versions of exendin peptide(s) for treating diabetes
03/19/1998CA2698393A1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) 1 alpha (.alpha.), hnf-1.beta. and hnf-4.alpha.
03/19/1998CA2280037A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
03/19/1998CA2277199A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998CA2266123A1 Method for preparing a plasmid dna
03/19/1998CA2265933A1 Sustained delivery device and methods of making and using the same
03/19/1998CA2265929A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998CA2265928A1 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2265925A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998CA2265913A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2265861A1 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998CA2265743A1 Ophthalmic composition of neurotrophic factor, optic nerve functional disorder-treating agent and method for treating optic nerve functional disorder
03/19/1998CA2265670A1 Nucleosome-based anti-tumor compositions
03/19/1998CA2265631A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
03/19/1998CA2265476A1 Conjugates useful in the treatment of prostate cancer
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2265458A1 Novel protein, its production and use
03/19/1998CA2265455A1 Granulocyte chemotactic protein 2 variant
03/19/1998CA2265454A1 Peptide prodrugs containing an alpha-hydroxyacid linker
03/19/1998CA2265445A1 Use of proteins as anti-retroviral agents
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998CA2264938A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998CA2264825A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2264646A1 Protein-lipid vesicles and autogenous vaccine comprising the same
03/19/1998CA2264563A1 Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
03/19/1998CA2264545A1 Novel human phosphorylase kinase gamma subunit
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/19/1998CA2259283A1 Method for treating amyotrophic lateral sclerosis
03/19/1998CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/18/1998EP0829488A1 Antigen peptide compound and immunoassay method
03/18/1998EP0829011A1 Inhibition of amylin release
03/18/1998EP0828854A1 Analytical and therapeutic agents
03/18/1998EP0828852A1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types
03/18/1998EP0828851A2 Tripeptidylpeptidase inhibitors
03/18/1998EP0828843A1 Recombinant heregulins and their biological functions upon receptor activation
03/18/1998EP0828833A1 Chemokine n-terminal deletion mutations
03/18/1998EP0828832A2 $g(D)P62, ITS VARIANTS, NUCLEIC ACID SEQUENCES ENCODING THEM, AND THEIR USES IN ANTI-CANCER GENE THERAPY
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828830A1 Eb1 gene product binds to apc
03/18/1998EP0828829A1 A gene switch comprising an ecdysone receptor
03/18/1998EP0828828A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
03/18/1998EP0828825A1 Methods of use of phthalocyanines to inactivate blood borne parasites
03/18/1998EP0828758A1 Chimeric fatty body-pro-grf analogs with increased biological potency
03/18/1998EP0828754A1 Dipeptides which promote release of growth hormone
03/18/1998EP0828751A1 Human neuropeptide receptor
1 ... 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 ... 3163